UCB SA Medicīniskās un farmaceitiskās izpētes,Anderlecht

1070 Anderlecht- Beļģija

Presentation - UCB SA

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,000 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

Executives - UCB SA Buy the executives list from same sector

Mr. Jean-Christophe Tellier

Izpilddirektors

Location -  UCB SA

Researchdreef 60 - 1070 Anderlecht - Beļģija

Key figures -  UCB SA

Activities -  UCB SA

Producer Distributor Service providers

Secondary activities within the Kompass classification

Other classifications (for some countries)

NACE-BEL (BE 2025) : Activités de société holding (64210)

NACE Rev.2.1 (EU 2025) : Activities of holding companies (6421)

NACE-BEL (BE 2008) : Activités des sociétés holding (64200)

NACE Rev.2 (EU 2008) : Activities of holding companies (6420)

ISIC 4 (WORLD) : Activities of holding companies (6420)

Follow us - UCB SA

Discover more on our Website

Kompass membership

Kompass ID? BE0024608

Legal information - UCB SA

Type Centrālais birojs
Year established 1998
Legal form NV/SA/AG
Activity (BEL25) Activités de société holding (64210)
Registration No. 2142567276
Registration No. 0403053608
VAT no BE0403053608
No employees (address) No 100 līdz 249 Employees
No employees No 100 līdz 249 Employees

General Information -  UCB SA

Export area
Centrālamerika, Ziemeļamerika, Dienvidamerika, Centrālāzija, Āzija-Klusā okeāna valstis, Centrāl- un Austrumeiropa, Rietumeiropa

Other Companies recommended by Kompass: